FilingFirehose · free AI preview
TScan Therapeutics, Inc.
TCRX · AI-generated SEC analysis preview · refreshes when data changes
TScan Therapeutics (TCRX) shows no cyber incidents or major red-flag 8-K filings in the past 90 days. However, this clean recent window captures only a narrow slice of the company's risk profile—low signal in a 90-day window does not mean low risk overall. The full $49 Report extends analysis across 12 months of filings, calculates shareholder dilution risk, maps financing history and capital burn patterns, and surfaces early AI-detected risk signals that precede formal announcements. The full $49 Report adds quantified dilution scoring, 12-month event context, and predictive risk flagging beyond the recent quiet period.
Want the full 5-section $49 Report on TCRX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.